FDA NDC Directory · JSON-LD · Markdown
NDC 0591-3524 · HUMAN PRESCRIPTION DRUG · GEL
| Labeler / Manufacturer | Actavis Pharma, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA091073 |
| Dosage form / route | GEL · TRANSDERMAL |
| Active ingredients | TESTOSTERONE (50 mg/5g) |
| Marketing started | 20171012 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).